SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is experiencing extreme volatility and a sharp sell-off following a significant earnings miss and weak forward guidance that signals a deceleration in growth. Investors are expressing deep frustration over management's performance and the company's deteriorating outlook, fueling intense debate across the community regarding whether the current price represents a value opportunity or the beginning of a long-term decline.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is currently attracting intense investor focus as the market weighs a recent 300 million dollar equity offering against expectations for sustained AI-driven revenue growth. Community sentiment remains polarized, with many investors debating whether the stock's recent volatility represents a long-term accumulation opportunity or a technical breakdown fueled by share dilution concerns.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle is trending as investors digest a string of quarterly financial beats and guidance raises that continue to drive bullish sentiment despite ongoing volatility from short interest and valuation debates. The community is actively discussing the stock's potential for a short squeeze, its strong operational fundamentals, and the impact of recent institutional capital inflows.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is surging following reports that the U.S. government may restrict new Chinese optical transceivers for data centers, a move that could favor domestic suppliers. Investors are actively discussing the stock's potential to capture market share from competitors, even as they weigh the company's manufacturing expansion against upcoming earnings catalysts.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are facing significant volatility following a second-quarter report that featured a minor revenue miss and cautious forward-looking guidance, prompting a revaluation of the company's growth trajectory. Community sentiment is deeply divided, with many traders viewing the double-digit price drop as a temporary overreaction and a value-buying opportunity given the company's strong cash flow and share buyback programs, while bears express concern over slowing growth and tightening margins.

Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman, and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.

Sweetgreen Inc - Ordinary Shares - Class A

Sweetgreen is facing significant downward pressure as the company lowered its full-year outlook following an industry-wide food safety scare involving a cyclospora outbreak, which has severely dampened consumer traffic. Investors are actively debating the company's long-term viability, with community sentiment split between those calling for an immediate management overhaul due to poor operational scaling and those viewing the current sell-off as a potential entry point for a turnaround.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is facing heavy downward pressure and significant investor concern following a reduced fiscal revenue outlook, fueling intense debate within the community regarding the company's long-term viability and growth prospects. While some retail traders are betting on a potential buyout or short squeeze due to high short interest, many are expressing frustration over the recent price decline and questioning the company's path to profitability.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is currently in the spotlight as investors balance robust GLP-1 demand and raised full-year guidance against pipeline setbacks and stiff competition from Eli Lilly. The community is actively debating the stock's long-term value, with many viewing the current price as a buying opportunity while others remain cautious due to intensifying pricing pressures and pipeline execution risks.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is trending as investors react to a short-seller report alleging regulatory and legal challenges, which has triggered heavy debate over the company's long-term operational health versus its fundamental value. The community remains deeply divided, with bulls pointing to insider buying and strong production potential as evidence of an oversold opportunity, while skeptics warn of ongoing litigation risks and financial instability.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors focus on its pivot from Bitcoin mining to an AI infrastructure and data center platform, bolstered by the recent completion of its Mirantis acquisition and strong institutional interest. While bullish sentiment is fueled by its massive power capacity and strategic partnerships, community discussions are currently dominated by heavy short interest, concerns over share dilution, and active debate regarding the company's ability to convert its gigawatt-scale pipeline into consistent revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Baxter Announces Cash Tender Offers

Baxter International Inc. (NYSE:BAX) (Baxter or the Company) today announced that it has commenced cash tender offers (each, an Offer and collectively, the Offers) for the maximum principal amount of validly tendered (and not validly withdrawn) notes set forth below (collectively, the Notes), such...

Why Baxter International Stock Skyrocketed by 19% This Week

Key PointsIt scored double beats on analyst estimates...

BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract

Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.

Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Baxter International (BAX) Surpasses Q2 Earnings and Revenue Estimates

Baxter (BAX) delivered earnings and revenue surprises of +55.56% and +5.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Baxter Int'l Q2 Profit Rises; Boosts FY26 Outlook; Stock Surges 15%

(RTTNews) - Health care company Baxter International, Inc. (BAX) reported Thursday net income attributable to shareholders for the second quarter of $126 million or $0.24 per share, up from $91 million or $0.18 per share in the prior-year quarter...

Baxter Reports Second-Quarter 2026 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2026. Our second-quarter results exceeded expectations on both the top and bottom lines, driven by both operating performance and an additional benefit from a tariff refund that was not...

Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?

Medical product makers face Q2 margin pressure from tariffs and inflation even as demand stays strong. See which earnings reports could surprise.

Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?

BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product holds offset steady demand across segments.

Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline

Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment sells connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment focuses on the sales of specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Baxter International Inc.

Baxter Stock Logs Worst Day In 3 Months On Margin Pain And Weak Guidance — Retail Sees Long-Term Buy Opportunity

Equity

Bearish Sentiment

Track BAX stock price, charts, news and real-time market activity on Stocktwits. Join the BAX message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Baxter International Inc stock.

BAX Stock Price Today - Baxter International Inc News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$27.01
Prev Close	$27.33
Open	$27.41
Dividend Yield	2.72%
50-Day Moving Average	$21.93
Beta	0.83
Avg. Volume	6.68M
PE Ratio	-14.01

52-Week High	$30.00
52-Week Low	$15.73
Market Capitalization	$14.13B
EPS (Annual)	-$2.05
Price to Book	2.25
Revenue Per Employee	$299,840.00

Feed

News

Sentiment

Earnings

Fundamentals

Info